| Literature DB >> 25110652 |
Abstract
We aimed to investigate differentially expressed genes (DEGs) in different stages after femoral fracture based on rat models, providing the basis for the treatment of sport-related fractures. Gene expression data GSE3298 was downloaded from Gene Expression Omnibus (GEO), including 16 chips. All femoral fracture samples were classified into earlier fracture stage and later fracture stage. Total 87 DEGs simultaneously occurred in two stages, of which 4 genes showed opposite expression tendency. Out of the 4 genes, Rest and Cst8 were hub nodes in protein-protein interaction (PPI) network. The GO (Gene Ontology) function enrichment analysis verified that nutrition supply related genes were enriched in the earlier stage and neuron growth related genes were enriched in the later stage. Calcium signaling pathway was the most significant pathway in earlier stage; in later stage, DEGs were enriched into 2 neurodevelopment-related pathways. Analysis of Pearson's correlation coefficient showed that a total of 3,300 genes were significantly associated with fracture time, none of which was overlapped with identified DEGs. This study suggested that Rest and Cst8 might act as potential indicators for fracture healing. Calcium signaling pathway and neurodevelopment-related pathways might be deeply involved in bone healing after femoral fracture.Entities:
Year: 2014 PMID: 25110652 PMCID: PMC4119616 DOI: 10.1155/2014/208751
Source DB: PubMed Journal: Int J Genomics ISSN: 2314-436X Impact factor: 2.326
The most significant upregulated and downregulated DEGs (top 10 of each) from earlier stage.
| Gene symbol | Full name |
| log2FC |
|---|---|---|---|
| Tmem200a | Transmembrane protein 200A | 0.0000116 | 3.28 |
| Oprm1 | Opioid receptor, mu 1 | 0.0000297 | 3.31 |
| Ccl20 | Chemokine (C-C motif) ligand 20 | 0.0001817 | 1.17 |
| Zbtb39 | Zinc finger and BTB domain containing 39 | 0.0002876 | 2.32 |
| LOC100910826 | Uncharacterized LOC100910826 | 0.0002924 | 1.65 |
| Rilpl1 | Rab interacting lysosomal protein-like 1 | 0.0003576 | 1.57 |
| Pemt | Phosphatidylethanolamine N-methyltransferase | 0.0005798 | 2.17 |
| Zc2hc1a | Zinc finger, C2HC-type containing 1A | 0.0006232 | 2.38 |
| Cdrt4 | CMT1A duplicated region transcript 4 | 0.0009013 | 2.41 |
| Ret | Ret proto-oncogene | 0.0013837 | 1.13 |
| Zfp278 | Zinc finger protein 278 | 0.0000801 | −2.24 |
| Kiaa0415 | KIAA0415 protein | 0.0001213 | −2.25 |
| Nfib | Nuclear factor I/B | 0.0001406 | −2.33 |
| Sycn | Syncollin | 0.0002121 | −1.9 |
| Htr7 | 5-Hydroxytryptamine (serotonin) receptor 7 | 0.0002318 | −2.05 |
| Mpp2 | Membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) | 0.0002686 | −1.83 |
| Scai | Suppressor of cancer cell invasion | 0.000331 | −2.09 |
| Apoe | Apolipoprotein E | 0.0004889 | −2.49 |
| Hrh1 | Histamine receptor H 1 | 0.0005174 | −2.41 |
| Kiss1r | KISS1 receptor | 0.0005912 | −1.92 |
The most significant upregulated and downregulated DEGs (top 10 of each) from later stage.
| Gene symbol | Full name |
| log2FC |
|---|---|---|---|
| Bcl2l1 | Bcl2-like 1 | 0.000093 | 2.37 |
| Tenm2 | Teneurin transmembrane protein 2 | 0.0002237 | 2.07 |
| Chrm4 | Cholinergic receptor, muscarinic 4 | 0.0003062 | 2.26 |
| Kcnk10 | Potassium channel, subfamily K, member 10 | 0.0004325 | 2.12 |
| Tti2 | TELO2 interacting protein 2 | 0.0006392 | 2.33 |
| Spatc1 | Spermatogenesis and centriole associated 1 | 0.0006546 | 2.91 |
| Sulf1 | Sulfatase 1 | 0.0009184 | 2.17 |
| Ankrd55 | Ankyrin repeat domain 55 | 0.0011436 | 2.05 |
| Cacng8 | Calcium channel, voltage-dependent, gamma subunit 8 | 0.001285 | 1.68 |
| Drd1a | Dopamine receptor D1A | 0.0013418 | 2.49 |
| Ephx4 | Epoxide hydrolase 4 | 0.0000341 | −2.22 |
| Wt1 | Wilms tumor 1 | 0.0001725 | −2.45 |
| Trpv6 | Transient receptor potential cation channel, subfamily V, member 6 | 0.0002677 | −2.48 |
| Shisa3 | Shisa homolog 3 ( | 0.000375 | −3.05 |
| Spink8 | Serine peptidase inhibitor, Kazal type 8 | 0.0004495 | −2.13 |
| Ank1 | Ankyrin 1, erythrocytic | 0.0007826 | −1.45 |
| Acsbg1 | Acyl-CoA synthetase bubblegum family member 1 | 0.0009768 | −2.58 |
| Rcbtb2 | Regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 | 0.0012021 | −1.92 |
| Ninj2 | Ninjurin 2 | 0.001204 | −2.08 |
| Nog | Noggin | 0.0016676 | −2.58 |
Figure 1Differentially expressed genes showed contrary regulation tendency in earlier stage and later stage.
Figure 2The interaction network of the obtained 87 DEGs. (a) The interaction network of 26 upregulated DEGs. (b) The interaction network of 57 downregulated DEGs. Red boxes: DEGs; blue boxes: reported gene in rats.
Figure 3The PPI network of Rest gene.
Figure 4The PPI network of Cst8 gene.
GO enrichment analysis of DEGs in earlier stage (upper) and later stage (lower).
| Category | Term | Gene number |
| Fold enrichment |
|---|---|---|---|---|
| Earlier stage | ||||
| GOTERM_BP_ALL | GO:0051179~localization | 140 | 5.56 | 1.57 |
| GOTERM_BP_ALL | GO:0048731~system development | 121 | 9.53 | 1.64 |
| GOTERM_BP_ALL | GO:0051234~establishment of localization | 122 | 3.92 | 1.60 |
| GOTERM_BP_ALL | GO:0065007~biological regulation | 249 | 4.01 | 1.29 |
| GOTERM_CC_ALL | GO:0045202~synapse | 38 | 4.14 | 2.76 |
| GOTERM_BP_ALL | GO:0006810~transport | 121 | 4.16 | 1.60 |
| GOTERM_BP_ALL | GO:0032502~developmental process | 141 | 4.71 | 1.52 |
| GOTERM_BP_ALL | GO:0007275~multicellular organismal development | 129 | 1.15 | 1.54 |
| GOTERM_BP_ALL | GO:0048856~anatomical structure development | 122 | 1.27 | 1.57 |
| GOTERM_BP_ALL | GO:0048666~neuron development | 34 | 2.41 | 2.76 |
| Later stage | ||||
| GOTERM_CC_ALL | GO:0045202~synapse | 32 | 3.67 | 2.53 |
| GOTERM_BP_ALL | GO:0051179~localization | 122 | 4.65 | 1.46 |
| GOTERM_MF_ALL | GO:0022838~substrate specific channel activity | 30 | 5.34 | 2.59 |
| GOTERM_CC_ALL | GO:0044456~synapse part | 25 | 5.88 | 2.90 |
| GOTERM_MF_ALL | GO:0022803~passive transmembrane transporter activity | 30 | 1.08 | 2.50 |
| GOTERM_MF_ALL | GO:0015267~channel activity | 30 | 1.08 | 2.50 |
| GOTERM_BP_ALL | GO:0048731~system development | 102 | 2.89 | 1.47 |
| GOTERM_MF_ALL | GO:0005215~transporter activity | 61 | 3.17 | 1.73 |
| GOTERM_MF_ALL | GO:0005261~cation channel activity | 23 | 3.29 | 2.76 |
| GOTERM_BP_ALL | GO:0030001~metal ion transport | 31 | 3.31 | 2.30 |
KEGG pathway analyses of DEGs in earlier stage (upper) and later stage (lower).
| Category | Term | Gene number |
| Fold enrichment |
|---|---|---|---|---|
| Earlier stage | ||||
| KEGG_PATHWAY | rno04020: calcium signaling pathway | 18 | 3.09 | 2.70 |
| KEGG_PATHWAY | rno00980: metabolism of xenobiotics by cytochrome P450 | 9 | 0.001370145 | 4.09 |
| KEGG_PATHWAY | rno04080: neuroactive ligand-receptor interaction | 20 | 0.003048821 | 2.08 |
| KEGG_PATHWAY | rno00982: drug metabolism | 9 | 0.004411985 | 3.41 |
| KEGG_PATHWAY | rno02010: abc transporters | 7 | 0.004863078 | 4.34 |
| Later stage | ||||
| KEGG_PATHWAY | rno04080: neuroactive ligand-receptor interaction | 23 | 6.18 | 2.58 |
| KEGG_PATHWAY | rno04360: axon guidance | 12 | 0.003586 | 2.78 |
The most significant negative and positive correlation between gene expression level and fracture time at P value < 0.005 (top 10 of each).
| GenBankAcc | Coefficient |
|
|---|---|---|
| AA859496 | −0.99368 | 6.08 |
| AI406518 | −0.99112 | 1.42 |
| AA892299 | −0.99081 | 1.55 |
| AW524669 | −0.98737 | 3.42 |
| BE104302 | −0.98477 | 5.45 |
| AW532414 | −0.98284 | 7.34 |
| BM386669 | −0.97924 | 0.000118 |
| BE115521 | −0.97904 | 0.000121 |
| NM_019243 | −0.97884 | 0.000124 |
| BM383832 | −0.97759 | 0.000143 |
| BF411794 | 0.990571 | 1.65 |
| AI412189 | 0.989311 | 2.26 |
| BG669998 | 0.989281 | 2.27 |
| BF412924 | 0.981708 | 8.61 |
| BF399367 | 0.981053 | 9.39 |
| BE098337 | 0.979558 | 0.000113 |
| AA943135 | 0.97682 | 0.000155 |
| BF284937 | 0.976587 | 0.000159 |
| BI295973 | 0.973675 | 0.000213 |
| AI236953 | 0.970683 | 0.000278 |
GenBankAcc: GenBank accession number.